FDA recall, , Moderate risk
LifeSouth Apheresis Platelets, Leukocytes Reduced, Irradiated
Apheresis Platelets, Leukocytes Reduced, Irradiated did not meet platelet yield specifications.
Recall ended Jul 17, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeSouth Community Blood Centers, Inc. began a recall of Apheresis Platelets, Leukocytes Reduced, Irradiated on April 15, 2026, because platelet yield did not meet specifications, and the distributed product was added to the FDA's Enforcement Report on July 17, 2026, with the recall classified that same day. The recall was listed in the FDA's weekly enforcement report on July 29, 2026, and involved product distributed in Georgia.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, Leukocytes Reduced, Irradiated
Recall details
- Company began the recall
- Sold in
- Company
- LifeSouth Community Blood Centers, Inc.
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99187
- Recall number
- B-0117-2026
All recalls from LifeSouth Community Blood Centers, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Archived
